-
Facilities Have Unequal Access to COVID Vaccine
A new analysis led by CP3 Associate Director Dr. Inma Hernandez examines geographic access to COVID-19 vaccines in the US. This work was conducted by faculty from Pitt Pharmacy and West Health Policy Center.
Read more about this work here -
Suda Receives ASHP Award
Dr. Katie Suda, CP3 Faculty Affiliate, is the recipient of the ASHP Foundation's 2020 Drug Therapy Research Award, for her impactful work examining antibiotic prescribing by dentists. Read the award-winning paper here.
Learn more about Dr. Suda's work here -
We Need a COVID-19 Vaccine Now, Says Gellad
In his latest piece for Wired, CP3 Director Walid Gellad explains why the COVID-19 vaccine safety data is enough to push forward.
Read the article -
COVID-19 Vaccine Seminar
On 10/20, we hosted expert panel from Pitt & CMU on 10/20 to learn about COVID-19 vaccine approval, hesitancy, allocation, & risk communication.
Watch the recording here
Improving the Quality, Safety and Efficiency of Medication Use
While prescription drugs are used by 80% of Americans, the improper, unsafe use of medications leads to billions of dollars of avoidable healthcare costs. The goal of the CP3 research program is to improve patient and prescriber decision-making, and inform the regulation and coverage of pharmaceuticals.
